AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
CONTINUOUS-INFUSION OF FACTOR-IX CONCENTRATE TO INDUCE IMMUNE TOLERANCE IN 2 PATIENTS WITH HEMOPHILIA-B
Authors: TENGBORN L BERNTORP E
Citation: L. Tengborn et E. Berntorp, CONTINUOUS-INFUSION OF FACTOR-IX CONCENTRATE TO INDUCE IMMUNE TOLERANCE IN 2 PATIENTS WITH HEMOPHILIA-B, Haemophilia, 4(1), 1998, pp. 56-59
PORT-A-CATH USAGE IN CHILDREN WITH HEMOPHILIA - EXPERIENCE OF 53 CASES
Authors: LJUNG R VANDENBERG M PETRINI P TENGBORN L SCHEIBEL E KEKOMAKI R EFFENBERGER W
Citation: R. Ljung et al., PORT-A-CATH USAGE IN CHILDREN WITH HEMOPHILIA - EXPERIENCE OF 53 CASES, Acta paediatrica, 87(10), 1998, pp. 1051-1054
THE INFLUENCE OF A SERINE-PROTEASE INHIBITOR, NAFAMOSTAT MESILATE, ONPLASMA COAGULATION, AND PLATELET ACTIVATION DURING EXPERIMENTAL EXTRACORPOREAL LIFE-SUPPORT (ECLS)
Authors: MELLGREN K SKOGBY M FRIBERG LG TENGBORN L WADENVIK H
Citation: K. Mellgren et al., THE INFLUENCE OF A SERINE-PROTEASE INHIBITOR, NAFAMOSTAT MESILATE, ONPLASMA COAGULATION, AND PLATELET ACTIVATION DURING EXPERIMENTAL EXTRACORPOREAL LIFE-SUPPORT (ECLS), Thrombosis and haemostasis, 79(2), 1998, pp. 342-347
3 NOVEL PROC GENE LESIONS CAUSING PROTEIN-C DEFICIENCY
Authors: HALLAM PJ MANNUCCI P TRIPODI A BEVAN D LAURSEN B TENGBORN L WACEY A COOPER DN
Citation: Pj. Hallam et al., 3 NOVEL PROC GENE LESIONS CAUSING PROTEIN-C DEFICIENCY, Clinical genetics, 54(3), 1998, pp. 231-233
EVIDENCE OF A LOCAL MECHANISM FOR DESMOPRESSIN-INDUCED TISSUE-TYPE PLASMINOGEN-ACTIVATOR RELEASE IN HUMAN FOREARM
Authors: WALL U JERN S TENGBORN L JERN C
Citation: U. Wall et al., EVIDENCE OF A LOCAL MECHANISM FOR DESMOPRESSIN-INDUCED TISSUE-TYPE PLASMINOGEN-ACTIVATOR RELEASE IN HUMAN FOREARM, Blood, 91(2), 1998, pp. 529-537
CONTINUOUS-INFUSION OF FACTOR-IX CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN 2 PATIENTS WITH HEMOPHILIA-B
Authors: TENGBORN L BERNTORP E
Citation: L. Tengborn et E. Berntorp, CONTINUOUS-INFUSION OF FACTOR-IX CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN 2 PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 1997, pp. 213-213
THE EFFECT OF NAFAMOSTAT MESILATE, A NEW SERINE-PROTEASE INHIBITOR, ON PLASMA COAGULATION AND PLATELET ACTIVATION DURING EXPERIMENTAL LONG-TERM PERFUSION
Authors: MELLGREN K SKOGBY M JARN S TENGBORN L WADENVIK H
Citation: K. Mellgren et al., THE EFFECT OF NAFAMOSTAT MESILATE, A NEW SERINE-PROTEASE INHIBITOR, ON PLASMA COAGULATION AND PLATELET ACTIVATION DURING EXPERIMENTAL LONG-TERM PERFUSION, Thrombosis and haemostasis, 1997, pp. 434-434
VASOPRESSIN ANALOG DDAVP INCREASES IN-VIVO RELEASE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BUT NOT VON-WILLEBRAND-FACTOR IN HUMAN FOREARM
Authors: JERN S WALL U TENGBORN L JERN C
Citation: S. Jern et al., VASOPRESSIN ANALOG DDAVP INCREASES IN-VIVO RELEASE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BUT NOT VON-WILLEBRAND-FACTOR IN HUMAN FOREARM, Thrombosis and haemostasis, 1997, pp. 542-542
ON ACQUIRED HEMOPHILIA-A IN SWEDEN
Authors: LINDGREN A STIGENDAL L TENGBORN L JOHNSSON H BERNTORP E
Citation: A. Lindgren et al., ON ACQUIRED HEMOPHILIA-A IN SWEDEN, Thrombosis and haemostasis, 1997, pp. 875-875
CLINICAL-EXPERIENCES OF THROMBOPROPHYLAXIS IN APC RESISTANT WOMEN DURING PREGNANCY
Authors: HELLGREN M KJELLBERG U TENGBORN L
Citation: M. Hellgren et al., CLINICAL-EXPERIENCES OF THROMBOPROPHYLAXIS IN APC RESISTANT WOMEN DURING PREGNANCY, Thrombosis and haemostasis, 1997, pp. 1270-1270
NEPHROTIC SYNDROME IN A BOY WITH HEMOPHILIA-B AND INHIBITORS DURING IMMUNE TOLERANCE TREATMENT (ITT)
Authors: TENGBORN L HANSSON S FASTH A LUBECK PO BERG A
Citation: L. Tengborn et al., NEPHROTIC SYNDROME IN A BOY WITH HEMOPHILIA-B AND INHIBITORS DURING IMMUNE TOLERANCE TREATMENT (ITT), Thrombosis and haemostasis, 1997, pp. 2653-2653
SYMPATHOADRENAL ACTIVATION AND MUSCARINIC RECEPTOR STIMULATION INDUCEACUTE RELEASE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BUT NOT VON-WILLEBRAND-FACTOR ACROSS THE HUMAN FOREARM
Authors: JERN C SELIN L TENGBORN L JERN S
Citation: C. Jern et al., SYMPATHOADRENAL ACTIVATION AND MUSCARINIC RECEPTOR STIMULATION INDUCEACUTE RELEASE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BUT NOT VON-WILLEBRAND-FACTOR ACROSS THE HUMAN FOREARM, Thrombosis and haemostasis, 78(2), 1997, pp. 887-891
RECOMBINANT, B-DOMAIN DELETED FACTOR-VIII (R-VIII SQ) - PHARMACOKINETICS AND INITIAL SAFETY ASPECTS IN HEMOPHILIA-A PATIENTS
Authors: FIJNVANDRAAT K BERNTORP E TENCATE JW JOHNSSON H PETERS M SAVIDGE G TENGBORN L SPIRA J STAHL C
Citation: K. Fijnvandraat et al., RECOMBINANT, B-DOMAIN DELETED FACTOR-VIII (R-VIII SQ) - PHARMACOKINETICS AND INITIAL SAFETY ASPECTS IN HEMOPHILIA-A PATIENTS, Thrombosis and haemostasis, 77(2), 1997, pp. 298-302
THE EFFECTS OF TRANSDERMAL ESTRADIOL AND ORAL PROGESTOGENS ON HEMOSTASIS VARIABLES
Authors: KROON UB TENGBORN L RITA H BACKSTROM AC
Citation: Ub. Kroon et al., THE EFFECTS OF TRANSDERMAL ESTRADIOL AND ORAL PROGESTOGENS ON HEMOSTASIS VARIABLES, British journal of obstetrics and gynaecology, 104, 1997, pp. 32-37
ELEVATED FIBRINOGEN LEVELS DECREASE FOLLOWING TREATMENT OF ACROMEGALY
Authors: LANDINWILHELMSEN K TENGBORN L WILHELMSEN L BENGTSSON BA
Citation: K. Landinwilhelmsen et al., ELEVATED FIBRINOGEN LEVELS DECREASE FOLLOWING TREATMENT OF ACROMEGALY, Clinical endocrinology, 46(1), 1997, pp. 69-74
COMPLEX FUNCTIONAL AND STRUCTURAL COAGULATION ABNORMALITIES IN THE CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME TYPE-I
Authors: STIBLER H HOLZBACH U TENGBORN L KRISTIANSSON B
Citation: H. Stibler et al., COMPLEX FUNCTIONAL AND STRUCTURAL COAGULATION ABNORMALITIES IN THE CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME TYPE-I, Blood coagulation & fibrinolysis, 7(2), 1996, pp. 118-126
LONG-TERM TREATMENT WITH GROWTH-HORMONE DECREASES PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-PLASMINOGEN ACTIVATOR IN GROWTH HORMONE-DEFICIENT ADULTS
Authors: JOHANSSON JO LANDIN K JOHANNSSON G TENGBORN L BENGTSSON BA
Citation: Jo. Johansson et al., LONG-TERM TREATMENT WITH GROWTH-HORMONE DECREASES PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-PLASMINOGEN ACTIVATOR IN GROWTH HORMONE-DEFICIENT ADULTS, Thrombosis and haemostasis, 76(3), 1996, pp. 422-428
A PATIENT WITH GLANZMANN THROMBASTHENIA AND EPISTAXIS SUCCESSFULLY TREATED WITH RECOMBINANT FACTOR VIIA
Authors: TENGBORN L PETRUSON B
Citation: L. Tengborn et B. Petruson, A PATIENT WITH GLANZMANN THROMBASTHENIA AND EPISTAXIS SUCCESSFULLY TREATED WITH RECOMBINANT FACTOR VIIA, Thrombosis and haemostasis, 75(6), 1996, pp. 981-982
FEMORAL-ARTERY WALL MORPHOLOGY, HEMOSTATIC FACTORS AND INTERMITTENT CLAUDICATION - ULTRASOUND STUDY IN MEN AT HIGH AND LOW-RISK FOR ATHEROSCLEROTIC DISEASE
Authors: AGEWALL S WIKSTRAND J WENDELHAG I TENGBORN L FAGERBERG B
Citation: S. Agewall et al., FEMORAL-ARTERY WALL MORPHOLOGY, HEMOSTATIC FACTORS AND INTERMITTENT CLAUDICATION - ULTRASOUND STUDY IN MEN AT HIGH AND LOW-RISK FOR ATHEROSCLEROTIC DISEASE, Haemostasis, 26(1), 1996, pp. 45-57
MICROALBUMINURIA, INSULIN SENSITIVITY AND HEMOSTATIC FACTORS IN NONDIABETIC TREATED HYPERTENSIVE MEN
Authors: AGEWALL S FAGERBERG B ATTVALL S LJUNGMAN S URBANAVICIUS V TENGBORN L WIKSTRAND J
Citation: S. Agewall et al., MICROALBUMINURIA, INSULIN SENSITIVITY AND HEMOSTATIC FACTORS IN NONDIABETIC TREATED HYPERTENSIVE MEN, Journal of internal medicine, 237(2), 1995, pp. 195-203
HEPARIN-INDUCED THROMBOCYTOPENIA DURING CONTINUOUS HEMOFILTRATION
Authors: SAMUELSSON O AMIRAL J ATTMAN PO BENNEGARD K BJORCK S LARSSON G TENGBORN L
Citation: O. Samuelsson et al., HEPARIN-INDUCED THROMBOCYTOPENIA DURING CONTINUOUS HEMOFILTRATION, Nephrology, dialysis, transplantation, 10(9), 1995, pp. 1768-1771
EFFECTS OF ERWINIA-ASPARAGINASE ON THE COAGULATION SYSTEM
Authors: CARLSSON H STOCKELBERG D TENGBORN L BRAIDE I CARNESKOG J KUTTI J
Citation: H. Carlsson et al., EFFECTS OF ERWINIA-ASPARAGINASE ON THE COAGULATION SYSTEM, European journal of haematology, 55(5), 1995, pp. 289-293
DIFFERENTIAL MECHANISMS FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND VON-WILLEBRAND-FACTOR RELEASE ACROSS THE HUMAN FOREARM
Authors: JERN C TENGBORN L SELIN L JERN S
Citation: C. Jern et al., DIFFERENTIAL MECHANISMS FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND VON-WILLEBRAND-FACTOR RELEASE ACROSS THE HUMAN FOREARM, Thrombosis and haemostasis, 73(6), 1995, pp. 900-900
PROPHYLACTIC TREATMENT WITH A B-DOMAIN-DELETED RECOMBINANT FACTOR-VIII (R-VII SQ) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA-A
Authors: BERNTORP E BRACKMANN HH DECHAVANNE M GAZENGEL C JOHNSSON H LAURIAN Y TENGBORN L STAHL C HOLM R
Citation: E. Berntorp et al., PROPHYLACTIC TREATMENT WITH A B-DOMAIN-DELETED RECOMBINANT FACTOR-VIII (R-VII SQ) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA-A, Thrombosis and haemostasis, 73(6), 1995, pp. 1011-1011
DELETION OF THE B-DOMAIN IN A RECOMBINANT FACTOR-VIII (R-VIII SQ) DOES NOT AFFECT THE MAIN KINETIC-PROPERTIES - 3 PHARMACOKINETIC STUDIES IN 36 PATIENTS WITH SEVERE HEMOPHILIA-A
Authors: BERNTORP E JOHNSSON H TENGBORN L VANDRAAT KF PETERS M TENCATE JW SAVIDGE G STAHL C HOLM R
Citation: E. Berntorp et al., DELETION OF THE B-DOMAIN IN A RECOMBINANT FACTOR-VIII (R-VIII SQ) DOES NOT AFFECT THE MAIN KINETIC-PROPERTIES - 3 PHARMACOKINETIC STUDIES IN 36 PATIENTS WITH SEVERE HEMOPHILIA-A, Thrombosis and haemostasis, 73(6), 1995, pp. 1014-1014
Risultati: 1-25 | 26-45